Denmark Pays 31 Wegovy and Ozempic Users for Rare Vision Loss as FDA Adds GLP-1 Eye Warning
Denmark has awarded about $2.3 million to 31 Wegovy and Ozempic users with NAION. The payments do not establish causation, but sudden visual changes require prompt medical care.
Medical Daily ·